[go: up one dir, main page]

NO823291L - Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse - Google Patents

Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse

Info

Publication number
NO823291L
NO823291L NO823291A NO823291A NO823291L NO 823291 L NO823291 L NO 823291L NO 823291 A NO823291 A NO 823291A NO 823291 A NO823291 A NO 823291A NO 823291 L NO823291 L NO 823291L
Authority
NO
Norway
Prior art keywords
hydroxy
substituted
compounds
mercapto
preparations
Prior art date
Application number
NO823291A
Other languages
English (en)
Inventor
Riccardo Scartazzini
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO823291L publication Critical patent/NO823291L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nye 7 g-aminooksazolyl-acetylamino-3-cefem-4-karboksyl-syre-forbindelser med formelen. hvori n betyr et helt tall fra 0-2, A betyr karbonyl, metylen eller en metylengruppe som er substituert med amino, beskyttet amino, hydroksy, beskyttet hydroksy, sulfo, beskyttet sulfo, eller med en gruppe med formelen =N-0-R, hvori R 4 betyr hydrogen, laverealkyl, substituert laverealkyl, cykloalkyl, substituert cykloalkyl, karbamoyl eller substituert karbamoyl, R-^ betyr hydrogen, laverealkyl, laverealkoksy, halogen eller en gruppe med formelen -CH-Rj,. hvori Rbetyr hydroksy, merkapto, forestret hydroksy eller merkapto, foretret hydroksy eller merkapto eller en ammoniogruppe, og R^ betyr karboksyl eller beskyttet karboksyl, hydrater og salter av disse forbindelser, har antibiotiske egenskaper og er virksomme mot grampositive og gramnegative mikroorganismer. De nye forbindelser kan anvendes f.eks. i form av antibiotisk virksomme preparater til behandling av infeksjoner. De nye forbindelser blir fremstilt på i og for seg kjent måte. Oppfinnelsen omfatter også mellomprodukter.
NO823291A 1981-09-30 1982-09-29 Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse NO823291L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH630381 1981-09-30
CH304982 1982-05-17
CH480782 1982-08-11

Publications (1)

Publication Number Publication Date
NO823291L true NO823291L (no) 1983-04-05

Family

ID=27174099

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823291A NO823291L (no) 1981-09-30 1982-09-29 Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse

Country Status (12)

Country Link
EP (1) EP0076452A3 (no)
DD (1) DD204256A5 (no)
DK (1) DK432582A (no)
ES (1) ES8402592A1 (no)
FI (1) FI823304L (no)
GB (1) GB2106519B (no)
GR (1) GR77677B (no)
MA (1) MA19602A1 (no)
NO (1) NO823291L (no)
PT (1) PT75626B (no)
RO (1) RO84457B (no)
ZW (1) ZW20982A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
JPS6197288A (ja) * 1984-10-19 1986-05-15 Kaken Pharmaceut Co Ltd セフアロスポリン化合物
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
HUT53892A (en) * 1989-04-07 1990-12-28 Technologishen Kom Za Promy Mi Process for producing synaminothiazolyl and synaminooxazolyl derivatives
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH527215A (de) * 1967-04-15 1972-08-31 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 3,7-disubstituierten Cephalosporinderivaten
FR2068419A1 (en) * 1969-10-27 1971-08-27 Fujisawa Pharmaceutical Co Antibacterial cephalosporin compsns
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
CA1088049A (en) * 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4430499A (en) * 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten

Also Published As

Publication number Publication date
RO84457A (ro) 1984-06-21
PT75626A (de) 1982-10-01
PT75626B (de) 1985-12-09
GR77677B (no) 1984-09-25
FI823304A7 (fi) 1983-03-31
GB2106519B (en) 1985-04-24
EP0076452A2 (de) 1983-04-13
FI823304L (fi) 1983-03-31
DK432582A (da) 1983-03-31
ES516013A0 (es) 1984-02-01
MA19602A1 (fr) 1983-04-01
ZW20982A1 (en) 1983-04-27
ES8402592A1 (es) 1984-02-01
EP0076452A3 (de) 1984-09-05
RO84457B (ro) 1984-08-30
DD204256A5 (de) 1983-11-23
FI823304A0 (fi) 1982-09-27
GB2106519A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DK518683A (da) Fremgangsmaade til fremstilling af 4aeepi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaaden
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
DK0888271T3 (da) Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
NO971625L (no) Nye peptider med immunomodulatoriske effekter
IT7826811A0 (it) Antibiotici prodotti mediante nuove speci di nocardia.
ES8504977A1 (es) Procedimiento para preparar -monohidrato de (+)-catequina.
NO823291L (no) Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse
ES459406A1 (es) Un procedimiento para la preparacion de un compuesto de pi- perazinilpirazina.
IL75116A (en) Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same
ZA853197B (en) N-substituted neuraminic acid derivatives and process for preparation thereof
DK0583578T3 (da) 17-(3-furyl)- og 17-(4-pyridazinyl)-5beta,14beta-androstanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse
DK444982A (da) Substituerede hydroxymalonsyrediamider, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempende midler
GB1544819A (en) Antibiotic substances derived from antibiotic 67-694(rosamicin)and processes for their preparation
GB1125820A (en) The uses of glutamic acid derivatives as preservatives
NO950665L (no) Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
AU563990B2 (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives
GB2020659A (en) Derivatives of 1,5-dimethylbicyclo (3.2.1) octane
ES425628A1 (es) Procedimiento de preparacion de derivados de piperidina sustituidos con amino.
DK140152B (da) Fremgangsmåde til fremstilling af et antibioticum kaldet fortimicin C eller syreadditionssalte deraf.
FR2027230A1 (en) Imidazolidin-2-ones herbicides
ES8107179A1 (es) Procedimiento de preparacion de nuevos productos sulfurados con grupo amida, que derivan de la anilina